0001127602-21-010883.txt : 20210316 0001127602-21-010883.hdr.sgml : 20210316 20210316185057 ACCESSION NUMBER: 0001127602-21-010883 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180315 FILED AS OF DATE: 20210316 DATE AS OF CHANGE: 20210316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENKOWITZ MICHAEL CENTRAL INDEX KEY: 0001673232 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 21747640 MAIL ADDRESS: STREET 1: C/O UNITED THERAPEUTICS CORP STREET 2: 1040 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4/A 1 form4a.xml PRIMARY DOCUMENT X0306 4/A 2018-03-15 2021-03-16 0001082554 UNITED THERAPEUTICS Corp UTHR 0001673232 BENKOWITZ MICHAEL C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 President and COO Common Stock 2235 D Stock Options 111.00 2018-03-15 4 A 0 85531 0 A 2021-03-15 2028-03-15 Common Stock 85531 85531 D Includes 237 shares acquired on March 4, 2021, under the United Therapeutics Corporation Employee Stock Purchase Plan. These performance-based stock options were initially awarded on March 15, 2018, subject to a three-year performance condition tied to average cash profit margin during 2018-2020, which was determined on February 24, 2021. Number of stock options reported represents the number of options earned based on performance. This Form 4/A is being filed to correct the expiration date of this award. /s/ John S. Hess, Jr. under Power of Attorney 2021-03-16